Private company

Fresh2 Group Ltd

Fresh2 Group Ltd is a medical laboratories services company based in Lishui, British Virgin Islands.1

Last updated Oct 20, 2026.

Overview

$1.4MRevenue, fiscal 20222
-$14.8MNet income, fiscal 20223
  • IndustryServices-Medical Laboratories1
  • HeadquartersNew York, New York1
  • Incorporated inVirgin Islands, British4
  • Business address880 3Rd Ave, Floor 7, New York, Ny 100224
  • Filer categoryNon-accelerated filer, Emerging growth company4
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

84.6%Gross margin3
-1064.1%Operating margin3
-1034.5%Net margin3
-49.4%Revenue growth, 20222
-$8.2MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue24¢$538.0K
  • Research and development61¢$1.4M
  • Interest2¢$34.0K
  • Income tax14¢$309.0K

Out of $1.4M in revenue.23 The company lost money this year.

Financial statements

Revenue5672$1.4M in 2022−8% since 2019
0$1.0M$2.0M$3.0M$4.0M2019: $1.6M$1.6M20192020: $3.1M$3.1M2020+102%2021: $2.8M$2.8M2021−10%2022: $1.4M$1.4M2022−49%
Gross profit5673$1.2M in 2022+75% since 2019
0$500.0K$1.0M$1.5M$2.0M2019: $689.0K$689.0K20192020: $2.0M$2.0M2020+187%2021: $1.9M$1.9M2021−3%2022: $1.2M$1.2M2022−37%
Operating income5673-$15.2M in 2022+19% since 2019
-$20.0M-$15.0M-$10.0M-$5.0M02019: -$12.8M-$12.8M20192020: -$14.5M-$14.5M2020+13%2021: -$17.6M-$17.6M2021+21%2022: -$15.2M-$15.2M2022−14%
Net income5673-$14.8M in 2022+2% since 2019
-$20.0M-$15.0M-$10.0M-$5.0M02019: -$14.5M-$14.5M20192020: -$12.3M-$12.3M2020−15%2021: -$18.6M-$18.6M2021+51%2022: -$14.8M-$14.8M2022−21%
Fiscal year20182019202020212022
Revenue$1.6M5$3.1M6$2.8M7$1.4M2
Cost of revenue$869.0K5$1.2M6$899.0K7$538.0K3
Gross profit$689.0K5$2.0M6$1.9M7$1.2M3
Research and development$1.4M5$1.8M6$2.5M7$1.4M3
Operating income-$12.8M5-$14.5M6-$17.6M7-$15.2M3
Interest$375.0K5$175.0K6$668.0K7$34.0K3
Income before tax-$19.0M7-$15.3M3
Income tax-$31.0K5-$13.0K6-$185.0K7-$309.0K3
Net income-$14.5M5-$12.3M6-$18.6M7-$14.8M3
Earnings per share-$1.377-$0.393
Earnings per share (diluted)-$1.377-$0.393
Shares (weighted, basic)13.6M shares338.2M shares3
Shares (weighted, diluted)13.6M shares338.2M shares3

Compare Fresh2 Group Ltd with another company

Corporate structure

Fresh2 Group Ltd sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Fresh2 Group Ltd

  • Immensus LLC Filed SC 13D on Fresh2 Group Ltd, latest Jul 27, 2023
  • ST FORTUNE GROUP LLC Filed SC 13G on Fresh2 Group Ltd, latest Mar 24, 2023
  • CRS Holdings Inc. Filed SC 13D/A on Fresh2 Group Ltd, latest Oct 12, 2022 (3 filings since Feb 14, 2022)
  • Fresh2 Group Ltd New York, New York

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Fresh2 Group Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Land$201.0K3 Dec 31, 2022
Buildings and improvements$2.3M3 Dec 31, 2022
Furniture and fixtures$1.9M3 Dec 31, 2022
Leasehold improvements1.4M CNY3 Dec 31, 2021
Construction in progress$280.0K3 Dec 31, 2022
Accumulated depreciation$40.0K3 Dec 31, 2022$2.0M7 Dec 31, 2021−98.0%
Property and equipment, net$2.5M3 Dec 31, 2022$3.2M7 Dec 31, 2021−21.7%
Operating-lease assets (leased space)$1.0M3 Dec 31, 2022

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$271.0K3 Dec 31, 2022$1.5M7 Dec 31, 2021−81.3%
Marketable securities, current$41.7M7 Dec 31, 2021
Long-term investments$156.0K3 Dec 31, 2022$145.0K7 Dec 31, 2021+7.6%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$2.0M7 Dec 31, 2021$341.0K6 Dec 31, 2020+487.1%
Intangible assets, net (excluding goodwill)$1.4M3 Dec 31, 2022
Finite-lived intangibles, gross$2.3M3 Dec 31, 2022$2.5M7 Dec 31, 2021−6.8%
Accumulated amortization-$181.0K3 Dec 31, 2022$253.0K7 Dec 31, 2021−171.5%
Finite-lived intangibles, net$27.0K3 Dec 31, 2022$1.4M7 Dec 31, 2021−98.1%
Customer relationships, net$2.1M3 Dec 31, 2022

Inventory

ItemLatestA year beforeChange
Inventory, total$30.0K3 Dec 31, 2022$77.0K7 Dec 31, 2021−61.0%

Leadership

Who has led Fresh2 Group Ltd, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Haohan Xu2024
2025
  • Chief executive officerHaohan Xu Jan 5, 2024 to Jan 16, 20248
Board members and other officers (5)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorAidong Chen named May 27, 2022 to Jun 13, 202213
  • Executive Officer, DirectorChris Chang Yu named Jun 13, 202213
  • Executive OfficerHe Yu named May 27, 2022 to Jun 13, 202213
  • Executive OfficerJinqiu Tang named May 27, 2022 to Jun 13, 202213
  • Executive OfficerWeidong Dai named May 27, 2022 to Jun 13, 202213
  • Executive OfficerXueDong Du named May 27, 2022 to Jun 13, 202213
  • Executive Officer, DirectorChang Yu named May 27, 202214
  • DirectorFeng Guo named May 27, 2022 to Jun 13, 202213
  • DirectorJianhua Shao named May 27, 2022 to Jun 13, 202213
  • DirectorPu Xing named May 27, 2022 to Jun 13, 202213
  • DirectorRen Luo named May 27, 2022 to Jun 13, 202213
  • DirectorSheng Liu named May 27, 2022 to Jun 13, 202213

Former names

  • AnPac Bio-Medical Science Co., Ltd.Sep 20, 2019 to May 2, 20234

Timeline

  1. Jun 26, 20248-K Other events15
  2. May 23, 20248-K Listing notice or transfer16
  3. Apr 22, 20248-K Listing notice or transfer17
  4. Apr 2, 20248-K Entered a material agreement; New debt or obligation; Unregistered sale of shares18
  5. Mar 27, 20248-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares19
  6. Mar 25, 20248-K Entered a material agreement; Unregistered sale of shares20
  7. Mar 25, 20248-K Entered a material agreement; Unregistered sale of shares21
  8. Feb 16, 20248-K Entered a material agreement22
  9. Feb 1, 20248-K Other events23
  10. Jan 29, 20248-K Listing notice or transfer24
  11. Jan 29, 20248-K Entered a material agreement; Completed an acquisition or sale; Other events25
  12. Jan 5, 2024New chief executive Haohan Xu becomes CEO8

Filings

121 filings to the SEC since October 2021: 4 annual reports, 11 major events, 7 insider forms, 5 large holders, 3 private raises, 91 other. The latest 20:

  1. Apr 17, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  2. Apr 2, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  3. Dec 23, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  4. Nov 14, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  5. Jul 24, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  6. Jun 26, 20248-K CURRENT REPORT EDGAR
  7. May 23, 20248-K CURRENT REPORT EDGAR
  8. Apr 22, 20248-K CURRENT REPORT EDGAR
  9. Apr 2, 20248-K CURRENT REPORT EDGAR
  10. Apr 2, 2024NT 10-K NOTIFICATION OF LATE FILING EDGAR
  11. Apr 2, 2024UPLOAD EDGAR
  12. Mar 27, 20248-K CURRENT REPORT EDGAR
  13. Mar 25, 20248-K CURRENT REPORT EDGAR
  14. Mar 25, 20248-K CURRENT REPORT EDGAR
  15. Mar 25, 2024CORRESP EDGAR
  16. Mar 25, 202420-F/A AMENDMENT NO. 2 TO FORM 20-F EDGAR
  17. Mar 5, 2024UPLOAD EDGAR
  18. Feb 16, 20248-K CURRENT REPORT EDGAR
  19. Feb 1, 20248-K CURRENT REPORT EDGAR
  20. Jan 29, 20248-K CURRENT REPORT EDGAR

The 121 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. May 30, 2022Raised $1.5 million in a private offering of equity Form D: 1 investor so far Form D
  2. May 27, 2022Raised $1.5 million in a private offering of equity Form D: 1 investor so far Form D
  3. May 16, 2022Raised $1.4 million in a private offering of equity Form D: 1 investor so far Form D

SEC filer profile

How Fresh2 Group Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARFresh2 Group Ltd1
  • CIK0001786511
  • Filer statusNon-accelerated filer<br>emerging growth company1
  • Incorporated inVirgin Islands, British1
  • Industry code (SIC)8071 Services-Medical Laboratories1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address880 3Rd Ave, Floor 7, New York, NY 100221
  • Phone1 917-397-68901
  • On EDGAR sinceSep 20, 20191
  • Filings190 in all: 6-K (88), CORRESP (14), 8-K (11), UPLOAD (10), 3 (6), 424B5 (5), F-1/A (5), 20-F (4)1
    All 33 form types

    D (4), S-8 (4), SC 13G (4), 20-F/A (3), EFFECT (3), FWP (3), SC 13D/A (3), 6-K/A (2), F-1 (2), F-6 POS (2), NT 20-F (2), SC 13D (2), 25-NSE (1), 3/A (1), 424B3 (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), DRSLTR (1), F-3 (1), F-6 (1), NT 10-K (1), RW (1), S-8 POS (1)

  • Latest filingsAnnual report (20-F) May 16, 2023
    Latest 8-K (8-K) Jun 26, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
    SEC EDGAROther events
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
    SEC EDGAROther events
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28